Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net income (loss)	$ 326,661	$ 28,067	$ (71,279)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation, amortization and accretion	60,043	47,929	42,288
Impairment of long-lived assets	138,050	0	9,729
Asset retirement obligation acceleration	0	280	5,259
Gain on interest rate swap termination	0	(5,494)	0
Amortization of debt related costs	4,300	1,249	676
Changes in fair value of contingent assets and liabilities	(9,275)	34,700	72,400
Charges incurred in connection with acquired IPR&D	0	260,000	0
Loss (gain) on extinguishment of debt	0	588	(889)
Provision for excess and obsolete inventory	7,914	7,145	4,057
Stock-based compensation	50,507	29,262	15,934
Gain on disposal of assets	(51,789)	0	(15,263)
Deferred taxes	(55,632)	(48,016)	4,437
Long-term indemnification receivable	3,929	9,554	7,121
Long-term income tax payable and other long-term liabilities	(3,103)	(12,477)	(7,912)
Other	4,855	4,059	2,512
Changes in assets and liabilities which provided (used) cash:
Accounts receivable	(68,637)	(128,460)	(33,102)
Inventory	(36,220)	(7,508)	(3,549)
Other current assets	(2,418)	(2,440)	(73)
Other long-term assets	0	(533)	0
Accounts payable	17,189	301	5,425
Accrued expenses and other liabilities	(81,114)	63,575	16,145
Net cash provided by operating activities	305,260	281,781	53,916
Investing activities
Capital expenditures	(46,555)	(18,347)	(12,140)
Proceeds from sale of assets, net	97,839	1,800	15,823
Acquisition of assets	(45,345)	(260,000)	0
Net cash provided by (used in) investing activities	5,939	(276,547)	3,683
Financing activities
Proceeds from issuance of common stock	1,933	1,375	767
Debt issuance costs	0	(95)	0
Proceeds from issuance of long-term debt, net	0	557,750	0
Contingent value rights settlement	(3,700)	0	0
Payments on long-term debt and other borrowings	(717)	(175,385)	(43,348)
Deferred financing costs	0	(2,315)	0
Proceeds from interest rate swap termination	0	5,583	0
Proceeds from stock option exercises	3,816	7,537	5,295
Payments for minimum statutory tax withholding related to net share settlement of equity awards	(14,394)	(7,759)	(2,046)
Repurchase of common stock	0	(75,000)	0
Net cash (used in) provided by financing activities	(13,062)	311,691	(39,332)
Effect of foreign exchange rates on cash and cash equivalents	(93)	(335)	(310)
Net increase in cash and cash equivalents and restricted cash	298,044	316,590	17,957
Cash and cash equivalents and restricted cash, beginning of year	417,241	100,651	82,694
Cash and cash equivalents and restricted cash, end of year	715,285	417,241	100,651
Reconciliation to amounts within the consolidated balance sheets
Cash and cash equivalents	713,656	415,652	98,508
Restricted cash included in other long-term assets	1,629	1,589	2,143
Cash, cash equivalents and restricted cash at end of period	715,285	417,241	100,651
Supplemental disclosure of cash flow information
Interest	15,387	5,064	6,284
Income taxes, net of refunds of $25, $50 and $315, respectively	151,579	54,049	215
Schedule of non-cash investing and financing activities
Additions of property, plant and equipment included in liabilities	6,978	2,370	1,262
Right-of-use asset obtained in exchange for operating lease liabilities	$ 29,396	$ 11,019	$ 683